AGP Executive Report
Last update: 2 hours agoAntitrust & Platform Economy: China’s market regulator fined Trip.com Group $765M (5.18B yuan total) for monopoly abuses in online travel, ordering refunds to hotels and requiring public rectification after an investigation into exclusive dealing and pressure on hotels to avoid rivals. AI Policy Clash: A public split in Silicon Valley is intensifying over open-source AI, as US regulators face pressure to restrict open models amid claims that Chinese systems gained an edge through improper data practices. Brain Health Research: A large study links dementia, alcohol addiction, and several psychiatric disorders to increased “brain ageing” patterns on MRI, while ADHD and autism showed no such shift. Clinical Trials Watch: India’s regulators gave the go-ahead for a Phase III trial of Zydus’ Desidustat oral tablets for sickle cell anemia after Phase II results, targeting patients with limited options. Public Health Warning: Doctors are urging people to avoid a viral China social-media weight-loss trend mixing external-use constipation medication with sugar-free tea, after hospital cases of severe side effects. Energy Transition: China’s wind and solar capacity surpassed thermal power for the first time during the 14th Five-Year Plan period, signaling continued momentum in low-carbon supply. Health & Wellness Tourism: Foreign diplomatic envoys visited Hainan, including Boao Lecheng’s medical tourism zone, highlighting interest in China’s healthcare and wellness institutions.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.